Table 2 Factors associated with a risk of osteoporosis in maintenance hemodialysis patients.
Variable | Model 1 | Model 2 | Model 3 | |||
---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Age per 5 years | 1.17 (1.04–1.32) | 0.010 | 1.16 (1.02–1.31) | 0.022 | 1.17 (1.02–1.34) | 0.029 |
Female | 4.26 (2.50–7.26) |  < 0.001 | 4.88 (2.79–8.51) |  < 0.001 | 3.24 (1.69–6.18) |  < 0.001 |
BMI, kg/m2 | ||||||
< 18.5 | 2.53 (1.26–5.10) | 0.009 | 2.78 (1.35–5.73) | 0.005 | 2.82 (1.25–6.38) | 0.013 |
18.5–24.9 | Reference | Reference | Reference | |||
≥ 25 | 0.26 (0.13–0.53) |  < 0.001 | 0.23 (0.11–0.48) |  < 0.001 | 0.30 (0.14–0.66) | 0.003 |
Dialysis vintage per year |  |  | 1.00 (0.97–1.03) | 0.7 | 1.00 (0.97–1.04) | 0.9 |
Hypertension |  |  | 0.66 (0.02–20.90) | 0.8 | 1.08 (0.03–35.80) | 1.0 |
Cardiovascular disease |  |  | 1.37 (0.79–2.38) | 0.3 | 1.33 (0.72–2.46) | 0.4 |
Diabetes mellitus |  |  | 1.79 (0.96–3.32) | 0.038 | 2.64 (1.31–5.34) | 0.007 |
Albumin, g/dL |  |  |  |  | 1.99 (0.80–4.97) | 0.1 |
Sodium, mEq/L |  |  |  |  | 1.02 (0.93–1.13) | 0.6 |
Calcium, mg/dL |  |  |  |  | 0.62 (0.36–1.06) | 0.08 |
Phosphate, mg/dL |  |  |  |  | 0.72 (0.54–0.95) | 0.020 |
PTH, pg/mL | ||||||
Q1 |  |  |  |  | 1.38 (0.61–3.09) | 0.4 |
Q2 | Â | Â | Â | Â | Reference | |
Q3 |  |  |  |  | 1.27 (0.56–2.85) | 0.6 |
Q4 |  |  |  |  | 1.56 (0.69–3.55) | 0.3 |
Kt/V ratios per 0.1 |  |  |  |  | 1.35 (1.13–1.61) |  < 0.001 |
Ca-based P binders |  |  |  |  | 0.41 (0.21–0.81) | 0.011 |
Ca-free P binders |  |  |  |  | 0.97 (0.54–1.74) | 1.0 |
Active vitamin D analog |  |  |  |  | 1.38 (0.65–2.94) | 0.4 |
Calcimimetic |  |  |  |  | 1.07 (0.59–1.92) | 0.8 |
PPI |  |  |  |  | 1.27 (0.71–2.27) | 0.4 |